Company Filing History:
2 out of 70 
1 out of 23 
1 out of 3 Years Active: 2018-2022
Title: Martin Messerle: Innovator in Viral Research
Introduction
Martin Messerle is a prominent inventor based in Hannover, Germany. He has made significant contributions to the field of virology through his innovative research and patented inventions. With a total of 2 patents, Messerle's work focuses on developing novel therapeutic agents to combat infectious diseases.
Latest Patents
Messerle's latest patents include groundbreaking inventions such as "Labyrinthopeptins as anti-viral agents." This invention relates to novel labyrinthopeptin derivatives that are useful for treating various infectious diseases, including those caused by human respiratory syncytial virus (RSV), Kaposi sarcoma-associated herpesvirus (KSHV), cytomegalovirus (CMV), dengue virus (DENV), chikungunya virus (CHIKV), tick-borne encephalitis virus (TBEV), vesicular stomatitis Indiana virus (VSV), zika virus (ZIKV), and hepatitis C virus (HCV). The labyrinthopeptin derivatives are also valuable for analyzing the mode of action of labyrinthopeptins. Additionally, the invention encompasses a combination of labyrinthopeptin A1 and A2 for use as a medicament in treating these infectious diseases.
Another significant patent is titled "Immune suppressor and its use." This invention introduces a new binder molecule that serves as an immune suppressor. It has been identified that the UL11 protein of human cytomegalovirus binds to the CD45 molecule, potentially altering the immune system of an individual. The invention also includes pharmaceutical compositions comprising the UL11 protein or its derivatives, aimed at delivering therapeutic molecules to cells expressing the CD45 molecule.
Career Highlights
Throughout his career, Martin Messerle has worked with esteemed institutions such as the Medical School of Hannover and the Helmholtz Centre for Infection Research. His research has significantly advanced the understanding of viral infections and their treatment.
Collaborations
Messerle has collaborated with notable colleagues, including Thomas Schulz and Mark Brönstrup, contributing to the success of his research endeavors.
Conclusion
Martin Messerle's innovative work in the field of virology has led to the development of important therapeutic agents aimed at combating infectious diseases. His contributions continue to impact the scientific community and improve public health outcomes.